SCHEMBL371112

SCHEMBL371112

O=C(O)c1c2ccccc2n2ccccc12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IDO1 P14902 3/20 0.51
▸ PTGS2 P35354 1/20 0.50
▸ EGFR P00533 2/20 0.49
▸ AGTR1 P30556 4/20 0.46
▸ ALDH1A1 P00352 4/20 0.45
▸ KDM4E B2RXH2 4/20 0.45
▸ HPGD P15428 2/20 0.45
▸ POLB P06746 1/20 0.45
▸ FNTA P49354 1/20 0.42
▸ FNTB P49356 1/20 0.42
▸ MEN1 O00255 2/20 0.42
▸ KMT2A Q03164 2/20 0.42
▸ CYP1A2 P05177 1/20 0.42
▸ GLA P06280 1/20 0.42
▸ CYP2C19 P33261 1/20 0.42
▸ HSD17B10 Q99714 1/20 0.42
▸ TACR1 P25103 1/20 0.40
▸ SRC P12931 1/20 0.40
▸ NPC1 O15118 1/20 0.40
▸ MAPT P10636 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL366887 0.83 KDM4E (0.56) IDO1PTGS2EGFRAGTR1ALDH1A1
SCHEMBL365934 0.83 KDM4E (0.45) IDO1PTGS2EGFRAGTR1ALDH1A1
SCHEMBL14463630 0.81 PTGS2 (0.58) IDO1PTGS2EGFRAGTR1ALDH1A1
SCHEMBL366810 0.81 PTGS2 (0.45) IDO1PTGS2EGFRALDH1A1KDM4E
SCHEMBL365778 0.80 EGFR (0.42) IDO1PTGS2EGFRAGTR1ALDH1A1
SCHEMBL366875 0.80 EGFR (0.42) IDO1PTGS2EGFRALDH1A1KDM4E
SCHEMBL366888 0.79 EGFR (0.44) IDO1PTGS2EGFRAGTR1ALDH1A1
SCHEMBL369887 0.79 EGFR (0.55) IDO1EGFRALDH1A1KDM4EPOLB
SCHEMBL365935 0.79 KDM4E (0.47) EGFRAGTR1ALDH1A1KDM4EHPGD
SCHEMBL7325858 0.79 IDO1 (0.56) IDO1EGFRALDH1A1KDM4EPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012007008-A1 INHIBITORS OF HDME EPITHERAPEUTICS APS (DK) 2012-01-19 — — WO disclosed
US-5998409-A GASTROINTESTINAL DISORDERS; CARDIOVASCULAR DISORDERS; NERVOUS SYSTEM DISORDERS SMITHKLINE BEECHAM PLC (GB) 1999-12-07 — — US disclosed
EP-0630376-B1 CONDENSED INDOLE DERIVATIVES AS 5-HT4-RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 1999-06-02 — — EP disclosed
EP-0630376-A1 CONDENSED INDOLE DERIVATIVES AS 5HT 4?-RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 1994-12-28 — — EP disclosed
WO-1993018036-A1 CONDENSED INDOLE DERIVATIVES AS 5HT4-RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 1993-09-16 — — WO disclosed
Send feedback